Literature DB >> 11522383

The α-Gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation.

U Galili1.   

Abstract

Many patients with failing organs (e.g., heart, liver or kidneys), do not receive the needed organ because of an insufficient number of organ donors. Pig xenografts have been considered as an alternative source of organs for transplantation. The major obstacle currently known to prevent pig to human xenotransplantation is the interaction between the human natural anti-Gal antibody and the α-gal epitope (Galα1-3Galβ1-4GlcNAc-R), abundantly expressed on pig cells. This short review describes the characteristics of anti-Gal and of the alpha-gal epitope, their role in inducing xenograft rejection and some experimental approaches for preventing this rejection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522383     DOI: 10.1016/s0300-9084(01)01294-9

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  44 in total

1.  Differential responses of UV-B irradiation on the viability and intracellular calcium influx in goat hepatocytes-in vitro effect.

Authors:  Vijayalakshmi Venkateshan; Naseem Begum Shakeel; Nalam Madhusudhan Rao; Vijayalakshmi Amash; Nandini Rangarajan; Chittoor Mohammed Habibullah
Journal:  Mol Cell Biochem       Date:  2004-11       Impact factor: 3.396

2.  Quantification of DNA in biologic scaffold materials.

Authors:  Thomas W Gilbert; John M Freund; Stephen F Badylak
Journal:  J Surg Res       Date:  2008-03-13       Impact factor: 2.192

3.  Growing the mandible: role of the periosteum and its cells.

Authors:  Pannee Ochareon; Susan W Herring
Journal:  Anat Rec (Hoboken)       Date:  2007-11       Impact factor: 2.064

Review 4.  Decellularized tissue and cell-derived extracellular matrices as scaffolds for orthopaedic tissue engineering.

Authors:  Christina W Cheng; Loran D Solorio; Eben Alsberg
Journal:  Biotechnol Adv       Date:  2014-01-10       Impact factor: 14.227

Review 5.  Lung xenotransplantation: recent progress and current status.

Authors:  Donald G Harris; Kevin J Quinn; Siamak Dahi; Lars Burdorf; Agnes M Azimzadeh; Richard N Pierson
Journal:  Xenotransplantation       Date:  2014-07-05       Impact factor: 3.907

6.  Rhamnose glycoconjugates for the recruitment of endogenous anti-carbohydrate antibodies to tumor cells.

Authors:  Rachael T C Sheridan; Jonathan Hudon; Jacquelyn A Hank; Paul M Sondel; Laura L Kiessling
Journal:  Chembiochem       Date:  2014-06-06       Impact factor: 3.164

7.  Examining the Biosynthesis and Xenoantigenicity of Class II Swine Leukocyte Antigen Proteins.

Authors:  Joseph M Ladowski; Gregory R Martens; Luz M Reyes; Zheng-Yu Wang; Devin E Eckhoff; Vera Hauptfeld-Dolejsek; Matt Tector; A Joseph Tector
Journal:  J Immunol       Date:  2018-03-14       Impact factor: 5.422

8.  Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat.

Authors:  Meng Fang; Sylviane Dewaele; Yun-Peng Zhao; Peter Stärkel; Valerie Vanhooren; Yue-Ming Chen; Xin Ji; Ming Luo; Bao-Mu Sun; Yves Horsmans; Anne Dell; Stuart M Haslam; Paola Grassi; Claude Libert; Chun-Fang Gao; Cuiying Chitty Chen
Journal:  Mol Cancer       Date:  2010-08-12       Impact factor: 27.401

9.  Lack of iGb3 and Isoglobo-Series Glycosphingolipids in Pig Organs Used for Xenotransplantation: Implications for Natural Killer T-Cell Biology.

Authors:  Fatima Tahiri; Yunsen Li; David Hawke; Luciane Ganiko; Igor Almeida; Steven Levery; Dapeng Zhou
Journal:  J Carbohydr Chem       Date:  2013-01-11       Impact factor: 1.667

10.  Production of alpha 1,3-galactosyltransferase-deficient pigs.

Authors:  Carol J Phelps; Chihiro Koike; Todd D Vaught; Jeremy Boone; Kevin D Wells; Shu-Hung Chen; Suyapa Ball; Susan M Specht; Irina A Polejaeva; Jeff A Monahan; Pete M Jobst; Sugandha B Sharma; Ashley E Lamborn; Amy S Garst; Marilyn Moore; Anthony J Demetris; William A Rudert; Rita Bottino; Suzanne Bertera; Massimo Trucco; Thomas E Starzl; Yifan Dai; David L Ayares
Journal:  Science       Date:  2002-12-19       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.